344 related articles for article (PubMed ID: 36297228)
1. Porphyromonas gingivalis Virulence Factors and Clinical Significance in Periodontal Disease and Coronary Artery Diseases.
Aleksijević LH; Aleksijević M; Škrlec I; Šram M; Šram M; Talapko J
Pathogens; 2022 Oct; 11(10):. PubMed ID: 36297228
[No Abstract] [Full Text] [Related]
2. Porphyromonas gingivalis outside the oral cavity.
Bregaint S; Boyer E; Fong SB; Meuric V; Bonnaure-Mallet M; Jolivet-Gougeon A
Odontology; 2022 Jan; 110(1):1-19. PubMed ID: 34410562
[TBL] [Abstract][Full Text] [Related]
3. Porphyromonas gingivalis: major periodontopathic pathogen overview.
Mysak J; Podzimek S; Sommerova P; Lyuya-Mi Y; Bartova J; Janatova T; Prochazkova J; Duskova J
J Immunol Res; 2014; 2014():476068. PubMed ID: 24741603
[TBL] [Abstract][Full Text] [Related]
4. Effect of Resveratrol on biofilm formation and virulence factor gene expression of Porphyromonas gingivalis in periodontal disease.
Kugaji MS; Kumbar VM; Peram MR; Patil S; Bhat KG; Diwan PV
APMIS; 2019 Apr; 127(4):187-195. PubMed ID: 30861212
[TBL] [Abstract][Full Text] [Related]
5. Spheres of influence: Porphyromonas gingivalis outer membrane vesicles.
Gui MJ; Dashper SG; Slakeski N; Chen YY; Reynolds EC
Mol Oral Microbiol; 2016 Oct; 31(5):365-78. PubMed ID: 26466922
[TBL] [Abstract][Full Text] [Related]
6. Melatonin Receptor Agonists as the "Perioceutics" Agents for Periodontal Disease through Modulation of Porphyromonas gingivalis Virulence and Inflammatory Response.
Zhou W; Zhang X; Zhu CL; He ZY; Liang JP; Song ZC
PLoS One; 2016; 11(11):e0166442. PubMed ID: 27832188
[TBL] [Abstract][Full Text] [Related]
7. Argeloside I inhibits the pathogenicity of Porphyromonas gingivalis TDC60.
Eltigani SA; Eltayeb MM; Bito T; Ichiyanagi T; Ishihara A; Arima J
J Biosci Bioeng; 2020 Dec; 130(6):644-649. PubMed ID: 32847740
[TBL] [Abstract][Full Text] [Related]
8. Proteolytic Activity-Independent Activation of the Immune Response by Gingipains from Porphyromonas gingivalis.
Ciaston I; Budziaszek J; Satala D; Potempa B; Fuchs A; Rapala-Kozik M; Mizgalska D; Dobosz E; Lamont RJ; Potempa J; Koziel J
mBio; 2022 Jun; 13(3):e0378721. PubMed ID: 35491845
[TBL] [Abstract][Full Text] [Related]
9. Targeting the HUβ Protein Prevents Porphyromonas gingivalis from Entering into Preexisting Biofilms.
Rocco CJ; Bakaletz LO; Goodman SD
J Bacteriol; 2018 Jun; 200(11):. PubMed ID: 29437850
[TBL] [Abstract][Full Text] [Related]
10. Genetic diversity in the oral pathogen Porphyromonas gingivalis: molecular mechanisms and biological consequences.
Tribble GD; Kerr JE; Wang BY
Future Microbiol; 2013 May; 8(5):607-20. PubMed ID: 23642116
[TBL] [Abstract][Full Text] [Related]
11. Pathogenesis of Important Virulence Factors of
Jia L; Han N; Du J; Guo L; Luo Z; Liu Y
Front Cell Infect Microbiol; 2019; 9():262. PubMed ID: 31380305
[TBL] [Abstract][Full Text] [Related]
12. Porphyromonas gulae Has Virulence and Immunological Characteristics Similar to Those of the Human Periodontal Pathogen Porphyromonas gingivalis.
Lenzo JC; O'Brien-Simpson NM; Orth RK; Mitchell HL; Dashper SG; Reynolds EC
Infect Immun; 2016 Sep; 84(9):2575-85. PubMed ID: 27354442
[TBL] [Abstract][Full Text] [Related]
13. Molecular Strategies Underlying Porphyromonas gingivalis Virulence.
Lunar Silva I; Cascales E
J Mol Biol; 2021 Apr; 433(7):166836. PubMed ID: 33539891
[TBL] [Abstract][Full Text] [Related]
14. Porphyromonas gingivalis: An Overview of Periodontopathic Pathogen below the Gum Line.
How KY; Song KP; Chan KG
Front Microbiol; 2016; 7():53. PubMed ID: 26903954
[TBL] [Abstract][Full Text] [Related]
15. Porphyromonas gingivalis platelet aggregation activity: outer membrane vesicles are potent activators of murine platelets.
Sharma A; Novak EK; Sojar HT; Swank RT; Kuramitsu HK; Genco RJ
Oral Microbiol Immunol; 2000 Dec; 15(6):393-6. PubMed ID: 11154438
[TBL] [Abstract][Full Text] [Related]
16. Porphyromonas gingivalis: an invasive and evasive opportunistic oral pathogen.
Bostanci N; Belibasakis GN
FEMS Microbiol Lett; 2012 Aug; 333(1):1-9. PubMed ID: 22530835
[TBL] [Abstract][Full Text] [Related]
17. The Role of
Zhang Z; Liu D; Liu S; Zhang S; Pan Y
Front Cell Infect Microbiol; 2020; 10():585917. PubMed ID: 33585266
[TBL] [Abstract][Full Text] [Related]
18. [Critical assessment of microbiological diagnostics in periodontal diseases with special focus on Porphyromonas gingivalis].
Walter C; Purucker P; Bernimoulin JP; Suttorp N; Meyer J; Weiger R
Schweiz Monatsschr Zahnmed; 2005; 115(5):415-24. PubMed ID: 15960451
[TBL] [Abstract][Full Text] [Related]
19. Thymoquinone inhibits biofilm formation and virulence properties of periodontal bacteria.
Tantivitayakul P; Kaypetch R; Muadchiengka T
Arch Oral Biol; 2020 Jul; 115():104744. PubMed ID: 32416351
[TBL] [Abstract][Full Text] [Related]
20. Roles of Porphyromonas gingivalis and its virulence factors in periodontitis.
Xu W; Zhou W; Wang H; Liang S
Adv Protein Chem Struct Biol; 2020; 120():45-84. PubMed ID: 32085888
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
